| Altered telomeres in tumors with ATRX and DAXX mutations CM Heaphy, RF De Wilde, Y Jiao, AP Klein, BH Edil, C Shi, C Bettegowda, ... Science 333 (6041), 425-425, 2011 | 1177 | 2011 |
| Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas Y Jiao, PJ Killela, ZJ Reitman, BA Rasheed, CM Heaphy, RF De Wilde, ... Oncotarget 3 (7), 709, 2012 | 682 | 2012 |
| Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes CM Heaphy, AP Subhawong, SM Hong, MG Goggins, EA Montgomery, ... The American journal of pathology 179 (4), 1608-1615, 2011 | 557 | 2011 |
| Tracking the clonal origin of lethal prostate cancer MC Haffner, T Mosbruger, DM Esopi, H Fedor, CM Heaphy, DA Walker, ... The Journal of clinical investigation 123 (11), 4918-4922, 2013 | 541 | 2013 |
| Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells H Konishi, M Mohseni, A Tamaki, JP Garay, S Croessmann, S Karnan, ... Proceedings of the National Academy of Sciences 108 (43), 17773-17778, 2011 | 206 | 2011 |
| Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic … RF De Wilde, CM Heaphy, A Maitra, AK Meeker, BH Edil, CL Wolfgang, ... Modern Pathology 25 (7), 1033-1039, 2012 | 178 | 2012 |
| Mammary field cancerization: molecular evidence and clinical importance CM Heaphy, JK Griffith, M Bisoffi Breast cancer research and treatment 118, 229-239, 2009 | 152 | 2009 |
| Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors P Cejas, Y Drier, KMA Dreijerink, LAA Brosens, V Deshpande, CB Epstein, ... Nature medicine 25 (8), 1260-1265, 2019 | 149 | 2019 |
| Telomeres: prognostic markers for solid tumors M Bisoffi, CM Heaphy, JK Griffith International Journal of Cancer 119 (10), 2255-2260, 2006 | 130 | 2006 |
| Alternative lengthening of telomeres in primary pancreatic neuroendocrine tumors is associated with aggressive clinical behavior and poor survival JY Kim, JA Brosnan-Cashman, S An, SJ Kim, KB Song, MS Kim, MJ Kim, ... Clinical Cancer Research 23 (6), 1598-1606, 2017 | 120 | 2017 |
| Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis E Fernandez-Egea, M Bernardo, CM Heaphy, JK Griffith, E Parellada, ... Schizophrenia bulletin 35 (2), 437-442, 2009 | 118 | 2009 |
| Telomere DNA content and allelic imbalance demonstrate field cancerization in histologically normal tissue adjacent to breast tumors CM Heaphy, M Bisoffi, CA Fordyce, CM Haaland, WC Hines, NE Joste, ... International journal of cancer 119 (1), 108-116, 2006 | 107 | 2006 |
| Markers of fibrosis and epithelial to mesenchymal transition demonstrate field cancerization in histologically normal tissue adjacent to breast tumors KA Trujillo, CM Heaphy, M Mai, KM Vargas, AC Jones, P Vo, KS Butler, ... International journal of cancer 129 (6), 1310-1321, 2011 | 103 | 2011 |
| Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death CM Heaphy, GS Yoon, SB Peskoe, CE Joshu, TK Lee, E Giovannucci, ... Cancer discovery 3 (10), 1130-1141, 2013 | 96 | 2013 |
| Association between cancer-free survival and telomere DNA content in prostate tumors CA Fordyce, CM Heaphy, NE Joste, AY Smith, WC Hunt, JK Griffith The Journal of urology 173 (2), 610-614, 2005 | 96 | 2005 |
| Abnormal glucose tolerance, white blood cell count, and telomere length in newly diagnosed, antidepressant-naive patients with depression C Garcia-Rizo, E Fernandez-Egea, BJ Miller, C Oliveira, A Justicia, ... Brain, behavior, and immunity 28, 49-53, 2013 | 92 | 2013 |
| Genetic analysis of small well-differentiated pancreatic neuroendocrine tumors identifies subgroups with differing risks of liver metastases A Pea, J Yu, L Marchionni, M Noe, C Luchini, A Pulvirenti, RF De Wilde, ... Annals of surgery 271 (3), 566-573, 2020 | 89 | 2020 |
| Circulating leukocyte telomere length and risk of overall and aggressive prostate cancer B Julin, I Shui, CM Heaphy, CE Joshu, AK Meeker, E Giovannucci, ... British journal of cancer 112 (4), 769-776, 2015 | 87 | 2015 |
| Molecular and morphologic correlates of the alternative lengthening of telomeres phenotype in high‐grade astrocytomas DN Nguyen, CM Heaphy, RF De Wilde, BA Orr, Y Odia, CG Eberhart, ... Brain Pathology 23 (3), 237-243, 2013 | 87 | 2013 |
| Telomere content correlates with stage and prognosis in breast cancer CA Fordyce, CM Heaphy, M Bisoffi, JL Wyaco, NE Joste, A Mangalik, ... Breast cancer research and treatment 99, 193-202, 2006 | 85 | 2006 |
